| 1. |
中華醫學會呼吸病學分會哮喘學組, 中國哮喘聯盟. 重癥哮喘診斷與處理中國專家共識. 中華結核和呼吸雜志, 2017, 40(11): 813-829.
|
| 2. |
C?té A, Godbout K, Boulet LP. The management of severe asthma in 2020. Biochem Pharmacol, 2020, 179: 114112.
|
| 3. |
Reihman AE, Holguin F, Sharma S. Management of severe asthma beyond the guidelines. Curr Allergy Asthma Rep, 2020, 20(9): 47.
|
| 4. |
Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS Guidelines on Definition, Evaluation and Treatment of Severe Asthma. Eur Respir J, 2014, 43: 343-373.
|
| 5. |
Shaw DE, Sousa AR, Fowler SJ, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J, 2015, 46(5): 1308-1321.
|
| 6. |
Kim MH, Kim SH, Park SY, et al. Characteristics of adult severe refractory asthma in Korea analyzed from the Severe Asthma Registry. Allergy Asthma Immunol Res, 2019, 11(1): 43-54.
|
| 7. |
van Bragt JJMH, Adcock IM, Bel EHD, et al. Characteristics and treatment regimens across ERS SHARP severe asthma registries. Eur Respir J, 2020, 55(1): 1901163.
|
| 8. |
中華醫學會呼吸病學分會哮喘學組. 支氣管哮喘防治指南(2020年版). 中華結核和呼吸雜志, 2020, 43(12): 1023-1048.
|
| 9. |
中華醫學會變態反應分會呼吸過敏學組, 中華醫學會呼吸病學分會哮喘學組. 中國過敏性哮喘診治指南(第一版, 2019年). 中華內科雜志, 2019, 58(9): 636-655.
|
| 10. |
Simpson JL, Phipps S, Baines KJ, et al. Elevated expression of the NLRP3 inflammasome in neutrophilic asthma. Eur Respir J, 2014, 43(4): 1067-1076.
|
| 11. |
Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med, 2009, 180(1): 59-99.
|
| 12. |
中華醫學會, 中華醫學會雜志社, 中華醫學會全科醫學分會, 等. 常規肺功能檢查基層指南(2018年). 中華全科醫師雜志, 2019, 18(6): 511-518.
|
| 13. |
王茹. 家庭收入、生活方式對中國成人肥胖的影響. 東南大學, 2020.
|
| 14. |
中華醫學會呼吸病學分會肺功能專業組. 肺功能檢查指南(第二部分)——肺量計檢查. 中華結核和呼吸雜志, 2014, 37(7): 481-486.
|
| 15. |
中華醫學會呼吸病學分會哮喘學組. 咳嗽的診斷與治療指南(2021). 中華結核和呼吸雜志, 2022, 45(1): 13-46.
|
| 16. |
Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med, 2011, 184(5): 602-615.
|
| 17. |
胡群, 吳雯雯, 姬郁林, 等. 多維度評估識別重癥支氣管哮喘的可治療特質. 中國呼吸與危重監護雜志, 2021, 20(4): 282-288.
|
| 18. |
王文雅, 林江濤, 周新, 等. 我國>14歲重癥哮喘患者的臨床特征和患病危險因素. 中華醫學雜志, 2020, 100(14): 1106-1111.
|
| 19. |
Wang WJ, Wang JH, Song GH, et al. Environmental and sensitization variations among asthma and/or rhinitis patients between 2008 and 2018 in China. Clin Transl Allergy, 2022, 12(2): e12116.
|
| 20. |
Abdo M, Trinkmann F, Kirsten AM, et al. Small airway dysfunction links asthma severity with physical activity and symptom control. J Allergy Clin Immunol Pract, 2021, 9(9): 3359-3368.
|
| 21. |
Bahmer T, Waschki B, Schatz F, et al. Physical activity, airway resistance and small airway dysfunction in severe asthma. Eur Respir J, 2017, 49(1): 1601827.
|
| 22. |
McBrien CN, Menzies-Gow A. The biology of eosinophils and their role in asthma. Front Med (Lausanne), 2017, 4: 93.
|
| 23. |
姚慶美, 陳玥, 黎友倫, 等. 重癥哮喘氣道上皮細胞損傷機制及潛在生物治療靶點. 中國呼吸與危重監護雜志, 2022, 21(12): 899-903.
|
| 24. |
Schleich F, Graff S, Guissard F, et al. Asthma in elderly is characterized by increased sputum neutrophils, lower airway caliber variability and air trapping. Respir Res, 2021, 22(1): 15.
|
| 25. |
程麗, 蔣毅, 岳倩如, 等. 呼出氣一氧化氮和外周血嗜酸粒細胞計數對嗜酸粒細胞型哮喘的診斷價值. 中華全科醫師雜志, 2020, 19(6): 502-506.
|
| 26. |
Merianos AL, Jandarov RA, Cataletto M, et al. Tobacco smoke exposure and fractional exhaled nitric oxide levels among U. S. adolescents. Nitric Oxide, 2021, 117: 53-59.
|
| 27. |
Porsbjerg C, Menzies-Gow A. Co-morbidities in severe asthma: clinical impact and management. Respirology, 2017, 22(4): 651-661.
|
| 28. |
Bruno A, Pace E, Cibella F, et al. Body mass index and comorbidities in adult severe asthmatics. Biomed Res Int, 2014, 2014: 607192.
|